We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
-4.32%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$19.2B
AUM Growth
-$805M
Cap. Flow
+$342M
Cap. Flow %
1.78%
Top 10 Hldgs %
25.36%
Holding
1,587
New
45
Increased
437
Reduced
460
Closed
44

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$364M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$172M
3
AMZN icon
Amazon
AMZN
+$161M
4
TSLA icon
Tesla
TSLA
+$125M
5
KO icon
Coca-Cola
KO
+$92.1M

Sector Composition

Rank Sector Weight
1 Technology 27.16%
2 Healthcare 21.2%
3 Financials 12.76%
4 Consumer Discretionary 10.28%
5 Consumer Staples 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$1.1B 5.73%
7,978,716
+2,322,137
+41% +$364M
MSFT icon
2
Microsoft
MSFT
$2.84T
$1.09B 5.66%
4,679,382
+161,832
+4% +$42.7M
AMZN icon
3
Amazon
AMZN
$2.5T
$448M 2.33%
3,965,110
+1,273,698
+47% +$161M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$3.9T
$448M 2.33%
4,657,707
+1,535,867
+49% +$172M
UNH icon
5
UnitedHealth
UNH
$382B
$403M 2.1%
798,588
+6,845
+0.9% +$3.6M
TMO icon
6
Thermo Fisher Scientific
TMO
$211B
$335M 1.74%
660,482
+2,558
+0.4% +$1.43M
PEP icon
7
PepsiCo
PEP
$186B
$308M 1.6%
1,886,698
+25,787
+1% +$4.44M
DHR icon
8
Danaher
DHR
$135B
$262M 1.36%
1,142,810
+65,429
+6% +$16M
LLY icon
9
Eli Lilly
LLY
$1.07T
$258M 1.34%
797,599
+193,167
+32% +$61.2M
V icon
10
Visa
V
$677B
$224M 1.17%
1,263,531
-45,452
-3% -$9.25M
KO icon
11
Coca-Cola
KO
$354B
$201M 1.04%
3,588,597
+1,482,158
+70% +$92.1M
BMY icon
12
Bristol-Myers Squibb
BMY
$127B
$201M 1.04%
2,825,896
-275,230
-9% -$20M
ABBV icon
13
AbbVie
ABBV
$458B
$192M 1%
1,432,683
+213,127
+17% +$30.6M
JNJ icon
14
Johnson & Johnson
JNJ
$635B
$192M 1%
1,173,503
-21,453
-2% -$3.63M
MDLZ icon
15
Mondelez International
MDLZ
$77.7B
$190M 0.99%
3,460,004
+95,033
+3% +$5.9M
TSLA icon
16
Tesla
TSLA
$1.24T
$188M 0.98%
707,876
+448,049
+172% +$125M
PFE icon
17
Pfizer
PFE
$140B
$180M 0.94%
4,120,966
+57,804
+1% +$2.81M
DIS icon
18
Walt Disney
DIS
$165B
$173M 0.9%
1,829,619
-384,253
-17% -$41.1M
MRK icon
19
Merck
MRK
$324B
$168M 0.87%
1,952,509
-35,735
-2% -$3.19M
NVDA icon
20
NVIDIA
NVDA
$5.01T
$163M 0.85%
13,421,100
-2,435,290
-15% -$38.5M
NKE icon
21
Nike
NKE
$61.9B
$161M 0.83%
1,931,486
-38,842
-2% -$4.18M
PG icon
22
Procter & Gamble
PG
$343B
$156M 0.81%
1,231,728
+44,163
+4% +$6.27M
BSX icon
23
Boston Scientific
BSX
$65.8B
$154M 0.8%
3,968,334
+240,315
+6% +$9.64M
EL icon
24
Estee Lauder
EL
$29B
$152M 0.79%
703,473
+33,811
+5% +$8.63M
BAC icon
25
Bank of America
BAC
$435B
$149M 0.78%
4,938,114
+913,245
+23% +$30.5M

Similar funds

KBC Group's Q3 2022 Portfolio in Review

As of Q3 2022, KBC Group held 1,587 positions worth $19.2B, down 4% from $20B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

KBC Group's Q3 2022 filing shows 45 new, 437 increased, 460 reduced and 44 closed positions. Its largest new stake was DT Midstream: 13,650 shares worth $708K. The largest sale was Old Dominion Freight Line, an estimated $84.4M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • KBC Group's largest Q3 2022 buy was DT Midstream: 13,650 shares worth $708K.
  • KBC Group added most to Apple in Q3 2022, an estimated $364M increase.
  • KBC Group's biggest Q3 2022 reduction was Old Dominion Freight Line, cutting an estimated $84.4M.
  • KBC Group fully exited Chimera Investment in Q3 2022, selling an estimated $2.35M.
  • KBC Group's ten largest holdings make up 25% of its $19.2B portfolio in Q3 2022.
  • KBC Group opened 45 new positions and closed 44 in Q3 2022.
  • KBC Group's portfolio value fell 4% quarter-over-quarter to $19.2B.

Based on KBC Group's 13F filing for Q3 2022, filed 8 Nov 2022.